Skip to main content

Table 1 Clinical characteristics of Heart Failure patients based on Preserved of reduced ejection fraction

From: Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study

Variable

Total patients (n = 311)

LVEF ≥ 50% (n = 164)

LVEF < 50% (n = 147)

P value

Women, n (%)

217 (69.77)

125 (76.22)

92 (62.59)

0.009

Age, Years (mean ± SD)

53.58 (±16.902)

54.20 (±16.587)

52.88 (±17.246)

0.496

Anemia, n (%)

118 (37.94)

65 (39.63)

53 (36.05)

0.516

AF, n (%)

79 (25.41)

47 (28.66)

32 (21.77)

0.163

DM, n (%)

4 (1.29)

2 (1.22)

2 (1.36)

0.912

Hypertension, n (%)

97 (0.312)

56 (34.15)

41 (27.89)

0.235

Heart Rate ( mean ± SD)

92.88 (±19.166)

95.60 (±21.177)

89.93 (±16.287)

0.009

Systolic BP

122.75 (±24.231)

125.06 (±26.911)

120.18 (±20.651)

0.072

NYHA Functional Class

   

0.274

Class III, n (%)

82 (26.37)

39 (23.78)

43 (29.25)

 

Class IV, n (%)

229 (73.63)

125 (76.22)

104 (70.75)

 

Etiology

 IHD, n (%)

49 (15.76)

18 (10.98)

31 (21.09)

0.015

 HHD, n (%)

50 (16.08)

33 (20.12)

17 (11.56)

0.040

 VHD, n (%)

127 (40.84)

77 (46.95)

50 (34.01)

0.020

 DCMP, n (%)

39 (12.54)

7 (4.27)

32 (21.77)

<0.001

 Cor pulmonale, n (%)

14 (4.50)

9 (5.48)

5 (3.40)

0.376

 Others, n (%)

32 (10.29)

20 (12.20)

12 (8.16)

0.243

  1. AF atrial fibrillation, BP blood pressure, DCMP dilated cardiomyopathy DM diabetes mellitus, HHD hypertensive heart disease, IHD ischemic heart disease, NYHA New York Heart Association, SD standard deviation